Ascensia Diabetes Care receives Health Canada approval for the app-enabled CONTOUR® NEXT ONE blood glucose monitoring system

A REMARKABLY ACCURATE METER THAT SEAMLESSLY INTEGRATES WITH SMART MOBILE DEVICES TO MAKE CONNECTED MANAGEMENT EASY FOR PEOPLE WITH DIABETES

Ascensia Diabetes Care today announced the approval of the CONTOUR® NEXT ONE blood glucose monitoring system (BGMS) in Canada, one of the next steps in the evolution of self-monitoring of blood glucose. As part of the system, the CONTOUR® NEXT ONE meter and CONTOUR® DIABETES App seamlessly connect to allow the app to capture the meter's remarkably accurate blood glucose readings.

The system features an easy-to-use wireless-enabled smart meter that links to a smart phone via Bluetooth™. The CONTOUR® NEXT ONE meter connects to the CONTOUR® DIABETES App, a mobile app that collects, stores and analyzes patient blood glucose readings from the meter. The app combines these with other data input by the patient to provide detailed information about their condition that can help them understand how their daily activities may impact their blood glucose results, including alerts for critical high or critical low readings. The blood glucose measurements and patterns that are identified can also be shared with healthcare professionals to help support management plans.

Not only does the CONTOUR® NEXT ONE system simplify diabetes management and help make it easier for more people with diabetes to use their smartphone to manage their condition, it has also been demonstrated to be one of the most accurate systems to date provided by Ascensia Diabetes Care.

"At Ascensia Diabetes Care we are dedicated to helping improve the lives of people with diabetes. The launch of the CONTOUR® NEXT ONE blood glucose monitoring system is the latest of our high quality solutions to meet the needs of the diabetes community," explained Russ Newsome, Region Head of North America, Ascensia Diabetes Care. "The value for both patients and healthcare professionals in having easy access to highly accurate data that tracks their condition over time could be significant," he added.

Published study data has shown the CONTOUR® NEXT ONE meter to be remarkably accurate. Canadian industry standards for blood glucose meters have an acceptable error range of 15%1 from lab readings. That means that readings on a meter can be 15% higher or lower, compared to the lab. CONTOUR® NEXT ONE meter results go beyond the industry standards, by coming within 8.4% of a lab reading.1

The CONTOUR® DIABETES App presents blood glucose readings in a simple, intuitive and easy-to-review way, which may help improve a patient's engagement with and understanding of their results. The system is also designed to evolve in the future, bringing new capabilities and features to help people with diabetes manage their condition.

______________________________________________

1 Christiansen M et al. Accuracy and user performance evaluation of a new blood glucose monitoring system in development for use with CONTOUR® NEXT test strips. Poster presented at the 15th Annual Meeting of the Diabetes Technology Society (DTS); 22–24 October, 2015; Bethesda, Maryland, USA.

About Ascensia Diabetes Care

Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes. Our mission is to empower people living with diabetes through innovative solutions that simplify and improve their lives. We use our innovation and specialist expertise in diabetes to develop high quality solutions and tools that make a positive, daily difference for people with diabetes.

Home to the world renowned CONTOURTM portfolio of blood glucose monitoring systems, our products combine advanced technology with user-friendly functionality that help people with diabetes to manage their condition. We are committed to continued research, innovation and development of new products and solutions. As a trusted partner in the diabetes community, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy, precision and reliability, and that we conduct our business compliantly and with integrity.

Ascensia Diabetes Care was established in 2016 through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd. Ascensia Diabetes Care products are sold in more than 125 countries. Following the close of the transaction in all countries, Ascensia Diabetes Care will have around 1,700 employees and operations in 38 countries.

For further information please visit the Ascensia Diabetes Care website at www.contournextone.ascensiadiabetes.ca.

CONTOUR® is a registered trademark of Ascensia Diabetes Care Holdings AG.

The Bluetooth™ word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks herein is under license.

SOURCE Ascensia Diabetes Care

CYREX ARRAY 2 PROVIDES CANADIAN CLINICIANS CUTTING-EDGE TECHNOLOGY FOR ACCURATE
ASSESSMENT AND MONITORING OF INTESTINAL BARRIER FUNCTION 

 Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, offers Array 2, an intestinal antigenic permeability screen. The Array 2 is the most advanced test on the market to accurately measure intestinal permeability or “leaky gut” as well as assess systemic Lipopolysaccharides (LPS)—a byproduct of bacteria. The Array 2 is unique among clinical testing in its ability to identify the route of damage occurring in the intestinal barrier.

Knowing the pathway of degeneration helps the practitioner narrow his/her focus in identifying the triggers causing damage and choose the most effective gut healing protocol for the patient. Dr. David Perlmutter, a renowned neurologist and leader in preventative medicine who recently released the New York Times Best Seller Brain Maker, said, “I consider the Cyrex Array 2 to be the most effective laboratory study available for evaluating gut permeability.”

Array 2 is recommended for patients who have food sensitivities, abnormal immune cell count and function, or who present multiple symptoms suggestive of autoimmune disorders, such as chronic fatigue, joint pain, skin issues and/or cognitive impairment.  Because of the significant correlation between the gut and brain barriers, Array 2 can also be used in combination with Cyrex’s Array 20, a potent tool for assessing permeability of the blood brain barrier.

"With gastrointestinal barrier integrity being a causal mechanism for so many autoimmune and metabolic diseases, there has never been a more important time for those practicing to quantify what is being observed clinically,” says Dr. Randall Gates, D.C, D.A.C.N.B. and Board Certified Chiropractic Neurologist and Dr. Martin Rutherford, D.C., C.F.M.P and Certified Functional Medicine Practitioner. “Simply, the Cyrex Array 2 allows us as practitioners to ascertain and demonstrate to patients the problem at hand.”

Physicians and other licensed healthcare professionals, as well as patients, interested in learning more about Array 2, 20 or any of the Cyrex Arrays that are part of the Cyrex System, are encouraged to visit www.joincyrex.com for additional information.

About Cyrex Laboratories
Cyrex is a clinical immunology laboratory specializing in functional immunology and autoimmunity. Cyrex offers multi-tissue antibody testing for the early detection and monitoring of today’s complex autoimmune conditions. Cyrex develops innovative testing arrays through continuous collaboration with leading experts in medical research and clinical practice. Cyrex technology is built on four pillars of excellence, including the antigen purification system, optimized antigen concentration, antigen-specific validation and parallel testing technology. Cyrex is a CLIA licensed laboratory based in Phoenix, Arizona and holds a Medical Device Establishment License in Canada.

Covergirl Lashblast Fusion - Review

I recently got the opportunity to review Covergirl's Lashblast fusion mascara. The package arrived at my condo nicely boxed. To my surprise there was also coupons for a discount to share with whomever I chose. Firstly I took out the Lashblast fusion mascara and opened it from its easy to open package. I then tried it on. Wow. No clumping! Thats a bonus and I can definitely see the length difference and volume just by using it. I immediately loved it. But what sealed the deal is that I was able to train all of my clients for the rest of the day and do a full cardio session without losing any of the volume! Train It Right approved!

image1

I shared the coupons with some of my clients and let them know I was reviewing the product and that I really liked it! They were happy to get the coupons! Over all we all won! Thank you covergirl and Bzzagent! I highly recommend this product if you are looking for a new mascara for your natural lashes.